Showing 1 - 8 of 8 Bincy Abraham
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0307

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease. ... Read more >

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease. ... Read more >

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis (OPAL)

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0307

The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >

Corrona Inflammatory Bowel Disease (IBD) Registry

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Zinah Rasheed

Phone: 713.363.7536

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease. ... Read more >

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 (JUNIPER)

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

This open-label extension and safety monitoring study is composed of two parts: Part 1 will evaluate the long-term safety and efficacy of continued etrolizumab treatment in participants with moderately to severely active Crohn's disease who were ... Read more >

PIANO

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0307

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >